Pankind Scientific Meeting
Pankind scientific meetings bring together leading researchers, clinicians and experts working to improve outcomes for people affected by pancreatic cancer.
These meetings provide a forum to share the latest research, encourage collaboration and identify priorities that will help accelerate progress in early detection, treatment and patient care.
Why these meetings matter
Progress in pancreatic cancer depends on more than individual breakthroughs. It requires coordination, shared knowledge, and a clear focus on the areas of greatest need.
Our meetings:
- Connect experts across disciplines and institutions
- Enable the rapid sharing of emerging research and data
- Identify gaps and set future research priorities
- Help translate discoveries into real-world impact for patients
Scientific Meeting 2026
Forward Science: The Next Chapter in Pancreatic Cancer Research
Building on the progress highlighted at the 2025 meeting — from emerging KRAS inhibitors and precision diagnostics to advances in earlier detection — this year’s meeting looks at what comes next.
As research continues to open up new possibilities for pancreatic cancer, the focus is increasingly on how we turn scientific advances into better outcomes for patients. The meeting will explore the questions, technologies and priorities shaping the next phase of pancreatic cancer research and care.
To register, email lisa@pankind.org.au
Explore past meetings
Scientific Meeting 2025
The Road to Treatment
Our 2025 meeting was our biggest yet with over 150 attendees coming together in Sydney. Explore the highlights, including notes from our international speakers Dr Eileen O’Reilly from Memorial Sloan Kettering and Dr Andy Lowy from UC San Diego.
Scientific Meeting 2024
Uniting for progress
Explore highlights from the 2024 meeting, and international plenary session speaker Urszula (Ula) Wasko-Kornberg from Columbia University.
Our approach
Our expert organising committee designs the Meeting's program to bring frontline insight across research, treatment and national strategy.
As part of our broader research strategy, these meetings help maximise the impact of every dollar invested - strengthening collaboration, and accelerating progress where it matters most.
